Global Insulin Like Growth Factor II Market Research Report 2021
Table of Contents1 Insulin Like Growth Factor II Market Overview
1.1 Product Overview and Scope of Insulin Like Growth Factor II
1.2 Insulin Like Growth Factor II Segment by Type
1.2.1 Global Insulin Like Growth Factor II Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dusigitumab
1.2.3 M-630
1.2.4 GM-6
1.2.5 M-610.27
1.2.6 Xentuzumab
1.2.7 Others
1.3 Insulin Like Growth Factor II Segment by Application
1.3.1 Insulin Like Growth Factor II Sales Comparison by Application: (2021-2027)
1.3.2 Breast Cancer
1.3.3 Hormone Sensitive Breast Cancer
1.3.4 Huntington Disease
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Global Insulin Like Growth Factor II Market Size Estimates and Forecasts
1.4.1 Global Insulin Like Growth Factor II Revenue 2016-2027
1.4.2 Global Insulin Like Growth Factor II Sales 2016-2027
1.4.3 Insulin Like Growth Factor II Market Size by Region: 2016 Versus 2021 Versus 2027
2 Insulin Like Growth Factor II Market Competition by Manufacturers
2.1 Global Insulin Like Growth Factor II Sales Market Share by Manufacturers (2016-2021)
2.2 Global Insulin Like Growth Factor II Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Insulin Like Growth Factor II Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Insulin Like Growth Factor II Manufacturing Sites, Area Served, Product Type
2.5 Insulin Like Growth Factor II Market Competitive Situation and Trends
2.5.1 Insulin Like Growth Factor II Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Insulin Like Growth Factor II Players Market Share by Revenue
2.5.3 Global Insulin Like Growth Factor II Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Like Growth Factor II Retrospective Market Scenario by Region
3.1 Global Insulin Like Growth Factor II Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Insulin Like Growth Factor II Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Insulin Like Growth Factor II Market Facts & Figures by Country
3.3.1 North America Insulin Like Growth Factor II Sales by Country
3.3.2 North America Insulin Like Growth Factor II Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Insulin Like Growth Factor II Market Facts & Figures by Country
3.4.1 Europe Insulin Like Growth Factor II Sales by Country
3.4.2 Europe Insulin Like Growth Factor II Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Insulin Like Growth Factor II Market Facts & Figures by Region
3.5.1 Asia Pacific Insulin Like Growth Factor II Sales by Region
3.5.2 Asia Pacific Insulin Like Growth Factor II Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Insulin Like Growth Factor II Market Facts & Figures by Country
3.6.1 Latin America Insulin Like Growth Factor II Sales by Country
3.6.2 Latin America Insulin Like Growth Factor II Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Insulin Like Growth Factor II Market Facts & Figures by Country
3.7.1 Middle East and Africa Insulin Like Growth Factor II Sales by Country
3.7.2 Middle East and Africa Insulin Like Growth Factor II Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Insulin Like Growth Factor II Historic Market Analysis by Type
4.1 Global Insulin Like Growth Factor II Sales Market Share by Type (2016-2021)
4.2 Global Insulin Like Growth Factor II Revenue Market Share by Type (2016-2021)
4.3 Global Insulin Like Growth Factor II Price by Type (2016-2021)
5 Global Insulin Like Growth Factor II Historic Market Analysis by Application
5.1 Global Insulin Like Growth Factor II Sales Market Share by Application (2016-2021)
5.2 Global Insulin Like Growth Factor II Revenue Market Share by Application (2016-2021)
5.3 Global Insulin Like Growth Factor II Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Boehringer Ingelheim GmbH
6.1.1 Boehringer Ingelheim GmbH Corporation Information
6.1.2 Boehringer Ingelheim GmbH Description and Business Overview
6.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor II Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Boehringer Ingelheim GmbH Product Portfolio
6.1.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.2 Genervon Biopharmaceuticals LLC
6.2.1 Genervon Biopharmaceuticals LLC Corporation Information
6.2.2 Genervon Biopharmaceuticals LLC Description and Business Overview
6.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Genervon Biopharmaceuticals LLC Product Portfolio
6.2.5 Genervon Biopharmaceuticals LLC Recent Developments/Updates
6.3 MedImmune LLC
6.3.1 MedImmune LLC Corporation Information
6.3.2 MedImmune LLC Description and Business Overview
6.3.3 MedImmune LLC Insulin Like Growth Factor II Sales, Revenue and Gross Margin (2016-2021)
6.3.4 MedImmune LLC Product Portfolio
6.3.5 MedImmune LLC Recent Developments/Updates
7 Insulin Like Growth Factor II Manufacturing Cost Analysis
7.1 Insulin Like Growth Factor II Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Insulin Like Growth Factor II
7.4 Insulin Like Growth Factor II Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Insulin Like Growth Factor II Distributors List
8.3 Insulin Like Growth Factor II Customers
9 Insulin Like Growth Factor II Market Dynamics
9.1 Insulin Like Growth Factor II Industry Trends
9.2 Insulin Like Growth Factor II Growth Drivers
9.3 Insulin Like Growth Factor II Market Challenges
9.4 Insulin Like Growth Factor II Market Restraints
10 Global Market Forecast
10.1 Insulin Like Growth Factor II Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Insulin Like Growth Factor II by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Insulin Like Growth Factor II by Type (2022-2027)
10.2 Insulin Like Growth Factor II Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Insulin Like Growth Factor II by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Insulin Like Growth Factor II by Application (2022-2027)
10.3 Insulin Like Growth Factor II Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Insulin Like Growth Factor II by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Insulin Like Growth Factor II by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Insulin Like Growth Factor II Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Insulin Like Growth Factor II Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Insulin Like Growth Factor II Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Insulin Like Growth Factor II Covered in This Study
Table 5. Global Insulin Like Growth Factor II Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Insulin Like Growth Factor II Sales Share by Manufacturers (2016-2021)
Table 7. Global Insulin Like Growth Factor II Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Insulin Like Growth Factor II Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Insulin Like Growth Factor II Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Insulin Like Growth Factor II Manufacturing Sites and Area Served
Table 11. Manufacturers Insulin Like Growth Factor II Product Type
Table 12. Global Insulin Like Growth Factor II Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Insulin Like Growth Factor II by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Like Growth Factor II as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Insulin Like Growth Factor II Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Insulin Like Growth Factor II Sales Market Share by Region (2016-2021)
Table 17. Global Insulin Like Growth Factor II Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Insulin Like Growth Factor II Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Insulin Like Growth Factor II Sales Market Share by Country (2016-2021)
Table 20. North America Insulin Like Growth Factor II Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Insulin Like Growth Factor II Revenue Market Share by Country (2016-2021)
Table 22. Europe Insulin Like Growth Factor II Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Insulin Like Growth Factor II Sales Market Share by Country (2016-2021)
Table 24. Europe Insulin Like Growth Factor II Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Insulin Like Growth Factor II Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Insulin Like Growth Factor II Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Insulin Like Growth Factor II Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Insulin Like Growth Factor II Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Insulin Like Growth Factor II Revenue Market Share by Region (2016-2021)
Table 30. Latin America Insulin Like Growth Factor II Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Insulin Like Growth Factor II Sales Market Share by Country (2016-2021)
Table 32. Latin America Insulin Like Growth Factor II Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Insulin Like Growth Factor II Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Insulin Like Growth Factor II Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Insulin Like Growth Factor II Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Insulin Like Growth Factor II Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Insulin Like Growth Factor II Revenue Market Share by Country (2016-2021)
Table 38. Global Insulin Like Growth Factor II Sales (K Pcs) by Type (2016-2021)
Table 39. Global Insulin Like Growth Factor II Sales Market Share by Type (2016-2021)
Table 40. Global Insulin Like Growth Factor II Revenue (Million US$) by Type (2016-2021)
Table 41. Global Insulin Like Growth Factor II Revenue Share by Type (2016-2021)
Table 42. Global Insulin Like Growth Factor II Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Insulin Like Growth Factor II Sales (K Pcs) by Application (2016-2021)
Table 44. Global Insulin Like Growth Factor II Sales Market Share by Application (2016-2021)
Table 45. Global Insulin Like Growth Factor II Revenue (Million US$) by Application (2016-2021)
Table 46. Global Insulin Like Growth Factor II Revenue Share by Application (2016-2021)
Table 47. Global Insulin Like Growth Factor II Price (USD/Pcs) by Application (2016-2021)
Table 48. Boehringer Ingelheim GmbH Corporation Information
Table 49. Boehringer Ingelheim GmbH Description and Business Overview
Table 50. Boehringer Ingelheim GmbH Insulin Like Growth Factor II Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Boehringer Ingelheim GmbH Insulin Like Growth Factor II Product
Table 52. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 53. Genervon Biopharmaceuticals LLC Corporation Information
Table 54. Genervon Biopharmaceuticals LLC Description and Business Overview
Table 55. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Product
Table 57. Genervon Biopharmaceuticals LLC Recent Developments/Updates
Table 58. MedImmune LLC Corporation Information
Table 59. MedImmune LLC Description and Business Overview
Table 60. MedImmune LLC Insulin Like Growth Factor II Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. MedImmune LLC Insulin Like Growth Factor II Product
Table 62. MedImmune LLC Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Insulin Like Growth Factor II Distributors List
Table 66. Insulin Like Growth Factor II Customers List
Table 67. Insulin Like Growth Factor II Market Trends
Table 68. Insulin Like Growth Factor II Growth Drivers
Table 69. Insulin Like Growth Factor II Market Restraints
Table 70. Global Insulin Like Growth Factor II Sales Forecast by Type (2022-2027) & (K Pcs)
Table 71. Global Insulin Like Growth Factor II Sales Market Share Forecast by Type (2022-2027)
Table 72. Global Insulin Like Growth Factor II Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 73. Global Insulin Like Growth Factor II Revenue Market Share Forecast by Type (2022-2027)
Table 74. Global Insulin Like Growth Factor II Sales Forecast by Application (2022-2027) & (K Pcs)
Table 75. Global Insulin Like Growth Factor II Sales Market Share Forecast by Application (2022-2027)
Table 76. Global Insulin Like Growth Factor II Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 77. Global Insulin Like Growth Factor II Revenue Market Share Forecast by Application (2022-2027)
Table 78. Global Insulin Like Growth Factor II Sales Forecast by Region (2022-2027) & (K Pcs)
Table 79. Global Insulin Like Growth Factor II Sales Market Share Forecast by Region (2022-2027)
Table 80. Global Insulin Like Growth Factor II Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 81. Global Insulin Like Growth Factor II Revenue Market Share Forecast by Region (2022-2027)
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Insulin Like Growth Factor II
Figure 2. Global Insulin Like Growth Factor II Market Share by Type in 2020 & 2027
Figure 3. Dusigitumab Product Picture
Figure 4. M-630 Product Picture
Figure 5. GM-6 Product Picture
Figure 6. M-610.27 Product Picture
Figure 7. Xentuzumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global Insulin Like Growth Factor II Market Share by Application in 2020 & 2027
Figure 10. Breast Cancer
Figure 11. Hormone Sensitive Breast Cancer
Figure 12. Huntington Disease
Figure 13. Muscular Dystrophy
Figure 14. Others
Figure 15. Global Insulin Like Growth Factor II Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Insulin Like Growth Factor II Market Size 2016-2027 (US$ Million)
Figure 17. Global Insulin Like Growth Factor II Sales 2016-2027 (K Pcs)
Figure 18. Global Insulin Like Growth Factor II Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Insulin Like Growth Factor II Sales Share by Manufacturers in 2020
Figure 20. Global Insulin Like Growth Factor II Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Insulin Like Growth Factor II Players: Market Share by Revenue in 2020
Figure 22. Insulin Like Growth Factor II Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Insulin Like Growth Factor II Sales Market Share by Region (2016-2021)
Figure 24. Global Insulin Like Growth Factor II Sales Market Share by Region in 2020
Figure 25. Global Insulin Like Growth Factor II Revenue Market Share by Region (2016-2021)
Figure 26. Global Insulin Like Growth Factor II Revenue Market Share by Region in 2020
Figure 27. U.S. Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E Insulin Like Growth Factor II Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Insulin Like Growth Factor II by Type (2016-2021)
Figure 52. Sales Market Share of Insulin Like Growth Factor II by Application (2016-2021)
Figure 53. Sales Market Share of Insulin Like Growth Factor II by Application in 2020
Figure 54. Revenue Share of Insulin Like Growth Factor II by Application (2016-2021)
Figure 55. Revenue Share of Insulin Like Growth Factor II by Application in 2020
Figure 56. Manufacturing Cost Structure of Insulin Like Growth Factor II
Figure 57. Manufacturing Process Analysis of Insulin Like Growth Factor II
Figure 58. Insulin Like Growth Factor II Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed